Navigation Links
Prevalent Prescription Drugs Abuse in the US

The Substance Abuse and Mental Health Services Administration borrowed data from the 2004 National Survey on Drug Use and Health, which revealed //that 2.4 million persons, 12 years of age or older, made non-medical use of prescription pain relievers, 12 months prior to the survey. Meanwhile, an estimated 2.1 million Americans has initiated the use of marijuana and 1 million, cocaine abuse.

The statistics revealed the following : 48 percent of new initiates used Vicodin, Lortab or Lorcet; 34.3 percent used Darvocet, Darvon, or Tylenol with codeine; 20 percent used Percocet, Percodan or Tylox; 18.4 percent used generic hydrocodone; 14.3 percent used generic codeine; 8.4 percent used Oxycontin; and 4.3 percent used morphine. Over half of the subjects who misused pain medications (54.9 percent) in 2004 were female, the report says.

"While overall illicit drug use continues to decline among our young people, we are always paying close attention to the data to identify any potential areas of concern," said Charles Curie, SAMHSA Administrator. "Abuse of prescription pain medication is dangerous and can lead to the destructive path of addiction. The initiation rates show we must continue our efforts to help the public confront and reduce all drug abuse.", he said.


'"/>




Page: 1

Related medicine news :

1. AIDS More Prevalent Among Teenage Girls In The US
2. Fatigue, Prevalent Among Patients Treated For Breast Cancer
3. New PPUD Syndrome Prevalent Among Indian Doctors In Britain
4. Intermittent Explosive Disorder is More Prevalent Now Than Before
5. Aids Seems More Prevalent Among Goan’s – Governor Visiond
6. Researchers Warn That Whooping Cough Is Still Very Prevalent
7. Polycystic Ovary Syndrome More Prevalent in Overweight Women
8. Opioid Abuse More Prevalent than Heroin
9. Female Circumcision highly Prevalent in Mali
10. Eating Disorders Highly Prevalent Among Gay and Bisexual Men
11. Lose Weight With New Wonder Slimming FDA approved Prescription Drug
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2016)... ... December 08, 2016 , ... Russ ... announced the first national #QuackGivesBack campaign which supported local breast cancer organizations during ... franchise-wide Quack Gives Back initiative, and we’re very pleased with the ...
(Date:12/8/2016)... ... 08, 2016 , ... Mirixa Corporation , a leading ... pharmacist-delivered patient care services, has announced the promotions of Karen Litsinger to senior ... of sales. , Litsinger joined Mirixa in 2008 after serving as a ...
(Date:12/8/2016)... ... ... David J. Dykeman , Ginger Pigott , and J. Rick ... West, Dec. 12, 2016, at the Fairmont Newport Beach in California. Greenberg Traurig is ... Sciences & Medical Technology Group have been featured speakers at every DeviceTalks conference since ...
(Date:12/8/2016)... , ... December 08, 2016 ... ... Suite 10.2 version gives development continuity to its innovative Unified Instance Manager ... management capacity. In addition, this new version optimizes the unattended auto-dialing system ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... STAT courier ... to be a convenient service for Texas, they are expanding their presence in Dallas. ... a hiring spree that will bring new jobs to the Dallas and Forth Worth ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... Research and Markets has announced the addition of the "Global ... ... market to grow at a CAGR of 6.83% during the period ... growth prospects of the global travel vaccines market for 2016-2020. To ... the sales of various vaccines administered to actively immunize meningococcal disease, ...
(Date:12/9/2016)... 2016  Axovant Sciences Ltd. (NYSE: ... on the treatment of dementia, today announced a ... 2b trial evaluating treatment with intepirdine (RVT-101), combined ... plus placebo in people with mild-to-moderate Alzheimer,s disease. ... to treatment was associated with reduced progression in ...
(Date:12/8/2016)... , Dec. 8, 2016 IRIDEX Corporation (NASDAQ: ... newly issued shares of common stock, $0.01 par value (the ... underwritten public offering.  The final terms of the Offering will ... pricing, and there can be no assurance as to whether ... expects to use the net proceeds it will receive from ...
Breaking Medicine Technology: